VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BCRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BCRXBioCryst Pharmaceuticals, Inc.
$10.17$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBCRXQuarterly Financials

BioCryst Pharmaceuticals, Inc. (BCRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BioCryst Pharmaceuticals, Inc. (BCRX) quarterly income statement — complete revenue, gross profit & net income history

BCRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue156.41M406.56M159.4M163.35M145.53M131.53M117.08M109.33M92.76M93.4M86.74M82.49M68.78M79.55M75.83M65.53M49.92M47.16M40.99M49.96M
Revenue Growth %7.48%209.09%36.14%49.41%56.89%40.83%34.98%32.54%34.87%17.42%14.39%25.88%37.77%68.68%84.97%31.17%161.94%1074.25%571.81%1640.13%
Cost of Goods Sold703.14M9.92M2.52M2.8M4.57M6.13M3.23M1.7M1.26M1.64M1.14M950K938K2.5M3.61M247K238K419K615K343K
COGS % of Revenue449.54%2.44%1.58%1.71%3.14%4.66%2.76%1.55%1.36%1.75%1.31%1.15%1.36%3.14%4.76%0.38%0.48%0.89%1.5%0.69%
Gross Profit-546.73M396.64M156.87M160.56M140.97M125.4M113.86M107.63M91.5M91.76M85.61M81.54M67.84M77.05M72.21M65.28M49.69M46.74M40.38M49.62M
Gross Margin %-349.54%97.56%98.42%98.29%96.86%95.34%97.24%98.45%98.64%98.25%98.69%98.85%98.64%96.86%95.24%99.62%99.52%99.11%98.5%99.31%
Gross Profit Growth %-487.84%216.29%37.78%49.17%54.07%36.66%33%32%34.87%19.1%18.54%24.9%36.54%64.85%78.84%31.58%278.24%1087.78%782.41%1628.18%
Operating Expenses154.87M136.65M127.28M130.77M119.74M129.91M106.17M98.87M105.98M134.43M97.53M102.24M96.25M123.36M89.66M100.01M99.64M98.92M84.96M79.2M
OpEx % of Revenue99.02%33.61%79.85%80.05%82.28%98.77%90.67%90.43%114.25%143.93%112.43%123.95%139.95%155.08%118.24%152.61%199.59%209.75%207.26%158.53%
Selling, General & Admin94.55M95.78M83.01M87.38M82.47M80.47M65.08M61.25M59.49M64.38M50.65M51M47.87M50.15M36.92M38.02M34.28M35.39M34.99M26.32M
SG&A % of Revenue60.45%23.56%52.08%53.49%56.67%61.18%55.59%56.02%64.13%68.93%58.39%61.82%69.6%63.05%48.69%58.01%68.67%75.04%85.36%52.69%
Research & Development60.32M41.2M44.27M43.39M37.27M49.44M41.08M37.62M46.49M70.05M46.88M51.25M48.39M73.21M52.74M61.99M65.36M63.53M49.97M52.87M
R&D % of Revenue38.56%10.13%27.77%26.56%25.61%37.59%35.09%34.41%50.12%75%54.04%62.12%70.35%92.03%69.55%94.59%130.92%134.72%121.9%105.83%
Other Operating Expenses0-335K000000000000000000
Operating Income-701.6M260.38M29.59M29.79M21.23M-4.51M7.69M8.76M-14.49M-42.67M-11.92M-20.7M-28.41M-46.31M-17.45M-34.72M-49.96M-52.18M-44.58M-29.58M
Operating Margin %-448.55%64.05%18.56%18.23%14.59%-3.43%6.57%8.01%-15.62%-45.68%-13.74%-25.1%-41.31%-58.22%-23.01%-52.98%-100.07%-110.64%-108.76%-59.21%
Operating Income Growth %-3405.22%5876.06%284.7%239.98%246.51%89.44%164.52%142.32%49.01%7.86%31.67%40.38%43.12%11.24%60.87%-17.38%2.76%0.44%-4.01%23.18%
EBITDA-701.6M264.43M29.93M30.11M21.56M-4.2M8M9.08M-14.18M-42.25M-11.5M-20.3M-28.01M-45.91M-17.06M-34.39M-49.64M-52.01M-44.35M-29.38M
EBITDA Margin %-448.55%65.04%18.77%18.44%14.81%-3.19%6.84%8.31%-15.29%-45.23%-13.26%-24.6%-40.73%-57.72%-22.49%-52.47%-99.43%-110.28%-108.2%-58.81%
EBITDA Growth %-3354.47%6397.43%273.93%231.63%252.01%90.06%169.59%144.74%49.37%7.99%32.57%40.98%43.57%11.71%61.55%-17.03%3.04%0.42%-3.88%23.34%
D&A (Non-Cash Add-back)04.04M335K329K331K309K311K320K306K423K420K407K405K396K389K335K317K171K229K199K
EBIT-701.6M262.15M31.79M28.07M24.25M-1.54M11.38M12.23M-10.51M-38.58M-8.47M-45.67M-25.27M-45.01M-16.22M-33.98M-50.08M3.25M-44.69M-29.7M
Net Interest Income0-11.24M-17.42M-19.07M-20.47M-20.88M-21.24M-21.18M-20.48M-20.12M-23.16M-25.16M-24.02M-23.75M-23.02M-23.41M-23.78M-18.77M-14.11M-13.48M
Interest Income2.26M2.89M2.24M2.52M3.02M3.57M3.59M3.55M4.03M4.46M4.18M3.75M3.38M2.7M1.76M609K54K14K9K13K
Interest Expense-19.78M14.13M19.66M21.58M23.49M24.45M24.83M24.73M24.51M24.58M27.34M28.91M27.4M26.46M24.77M24.02M23.84M18.78M14.12M13.49M
Other Income/Expense-19.21M-12.37M-17.46M-23.3M-20.47M-21.48M-21.14M-21.26M-20.53M-20.49M-23.9M-53.88M-24.25M-25.15M-23.55M-23.28M-23.96M36.65M-14.22M-13.62M
Pretax Income-720.81M248.02M12.13M6.49M758K-25.99M-13.45M-12.5M-35.01M-63.16M-35.82M-74.59M-52.66M-71.47M-41M-58M-73.92M-15.53M-58.8M-43.2M
Pretax Margin %-460.84%61%7.61%3.97%0.52%-19.76%-11.48%-11.43%-37.75%-67.62%-41.29%-90.42%-76.57%-89.84%-54.07%-88.51%-148.06%-32.92%-143.44%-86.47%
Income Tax1M2.17M-769K1.4M726K804K586K172K365K-1.43M330K740K671K76K1.52M856K279K2.25M00
Effective Tax Rate %-0.14%0.88%-6.34%21.6%95.78%-3.09%-4.36%-1.38%-1.04%2.27%-0.92%-0.99%-1.27%-0.11%-3.71%-1.48%-0.38%-14.51%0%0%
Net Income-721.81M245.84M12.9M5.08M32K-26.8M-14.03M-12.67M-35.38M-61.73M-36.15M-75.33M-53.33M-71.54M-42.52M-58.86M-74.2M-17.78M-58.8M-43.2M
Net Margin %-461.48%60.47%8.09%3.11%0.02%-20.37%-11.99%-11.59%-38.14%-66.09%-41.67%-91.31%-77.54%-89.94%-56.07%-89.82%-148.62%-37.7%-143.44%-86.47%
Net Income Growth %-2255762.5%1017.5%191.92%140.12%100.09%56.59%61.18%83.17%33.66%13.71%14.98%-27.98%28.12%-302.39%27.69%-36.25%-15.42%70.61%-27.51%-11.89%
Net Income (Continuing)-721.81M245.84M12.9M5.08M32K-26.8M-14.03M-12.67M-35.38M-61.73M-36.15M-75.33M-53.33M-71.54M-42.52M-58.86M-74.2M-17.78M-58.8M-43.2M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.981.120.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38-0.23-0.32-0.40-0.10-0.33-0.24
EPS Growth %-961.54%183.86%133.33%100%58.06%63.16%85%39.29%18.42%17.39%-25%30%-288.55%30.3%-33.33%-11.11%71.24%-26.92%0%
EPS (Basic)-2.981.170.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38-0.23-0.32-0.40-0.10-0.33-0.24
Diluted Shares Outstanding242.26M219.26M219.88M219.89M215.26M207.38M206.91M206.43M206.06M201.41M189.64M189.12M188.51M186.92M186.18M185.6M184.9M181.84M179.11M178.13M
Basic Shares Outstanding242.26M210.97M210.18M209.52M208.88M207.38M206.91M206.43M206.06M201.41M189.64M189.12M188.51M186.92M186.18M183.93M184.9M181.84M179.11M178.13M
Dividend Payout Ratio--------------------